SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Lizard King's Trading Swamp -- Ignore unavailable to you. Want to Upgrade?


To: TATRADER who wrote (5172)3/16/1998 3:38:00 PM
From: majormember  Read Replies (1) | Respond to of 7396
 
TATRADER,

You called SNRS PERFECTLY; just as you were the ONLY
one who called the APCO pullback. You are the best
TA person on S.I., IMO.

As a long term holder of SNRS, I'm looking for $35 in 12 mo.
VISX/BEAM both went over $35, and SNRS is the ONLY maker
of non-invasive treatment for hyperopia. FDA approval is
certain, time frame shorter as FDA is allowing "both eyes-same
time" cutting 6 months off final PMA. I'm heavy in this one...

Best Wishes,
Skane